Enveric Biosciences, Inc (ENVB) 8-K, filed Dec 15, 2020

UNITEDSTATES

SECURITIESAND EXCHANGE COMMISSION

Washington,D.C. 20549

FORM8-K

CURRENTREPORT

Pursuantto Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): December 15, 2020

Ameri Holdings, Inc.
(Exact<br> name of registrant as specified in its charter)
Delaware	001-38286	95-4484725
---	---	---
(State or Other Jurisdiction<br><br> <br>of Incorporation)	(Commission<br><br> <br>File Number)	(IRS Employer<br><br> <br>Identification No.)
5000<br> Research Court, Suite 750, Suwanee, Georgia	30024
---	---
(Address<br> of Principal Executive Offices)	(Zip<br> Code)

Registrant’s Telephone Number, Including Area Code: (770) 935-4152

(Former<br> Name or Former Address, If Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol	Name of Each Exchange on Which Registered
Common<br> Stock $0.01 par value per share	AMRH	The<br> NASDAQ Stock Market LLC
Warrants<br> to Purchase Common Stock	AMRHW	The<br> NASDAQ Stock Market LLC

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]	Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]	Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
---	---
[ ]	Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
---	---
[ ]	Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
---	---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [X]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Item5.07. Submission of Matters to a Vote of Security Holders.

Ameri Holdings, Inc. (the “Company”) held its 2020 Annual Meeting of Stockholders (the **“**Meeting”) on December 15, 2020.

As of October 30, 2020, the record date for the Meeting, there were 6,671,569 shares of our common stock outstanding.

At the Meeting, the stockholders voted on the following two proposals and cast their votes as follows:

1. To elect the four (4) persons named herein as nominees for directors of the Company, to hold office until the next annual meeting of stockholders and until their respective successors have been duly elected and qualified.

Name
Srinidhi “Dev” Devanur	1,322,583	140,248	2,827,118
Dimitrios J. Angelis	1,331,435	131,081	2,827,118
Thoranath Sukumaran	1,347,117	110,721	2,827,118
Carmo Martella	1,348,102	109,241	2,827,118

2. To ratify the appointment of Ram Associates as the Company’s independent auditors for the fiscal year ending December 31, 2020.

Votes For		Votes Against		Votes Abstained
	4,088,373		31,689		215,681

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

December<br> 15, 2020	AMERI<br> HOLDINGS, INC.
	By:	/s/ Barry Kostiner
	Name:	Barry Kostiner
	Title:	Chief Financial Officer

Enveric Biosciences, Inc 8-K, filed Dec 15, 2020

About this 8-K

Items reported